Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 10/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 6/20 | 1.00 |
| ▸ | ABCC1 | P33527 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.81 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.81 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.81 |
| ▸ | LMNA | P02545 | 1/20 | 0.76 |
| ▸ | TP53 | P04637 | 1/20 | 0.76 |
| ▸ | MAPT | P10636 | 1/20 | 0.76 |
| ▸ | CASP1 | P29466 | 1/20 | 0.76 |
| ▸ | CASP7 | P55210 | 1/20 | 0.76 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.67 |
| ▸ | TUBB | P07437 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pentamethylquercetin SCHEMBL30168918 | 1.00 | ABCG2 (1.00) | ABCG2ABCB1ABCC1KDM4ECYP3A4 | |
| Pentamethylquercetin SCHEMBL30168919 | 1.00 | ABCG2 (1.00) | ABCG2ABCB1ABCC1KDM4ECYP3A4 | |
| Pentamethylquercetin SCHEMBL29725289 | 1.00 | ABCG2 (1.00) | ABCG2ABCB1ABCC1KDM4ECYP3A4 | |
| Tetramethylkaempferol SCHEMBL1664159 | 0.90 | ADORA3 (1.00) | ABCG2ABCB1ABCC1KDM4ECYP3A4 | |
| SCHEMBL4286969 | 0.89 | ABCG2 (0.87) | ABCG2ABCB1ABCC1KDM4ECYP3A4 | |
| Retusin SCHEMBL29496204 | 0.89 | ABCG2 (1.00) | ABCG2ABCB1ABCC1KDM4ECYP3A4 | |
| Retusin SCHEMBL1421755 | 0.89 | ABCG2 (1.00) | ABCG2ABCB1ABCC1KDM4ECYP3A4 | |
| SCHEMBL1208084 | 0.88 | ABCG2 (0.79) | ABCG2ABCB1ABCC1KDM4ECYP3A4 | |
| SCHEMBL20464068 | 0.88 | ADORA3 (1.00) | ABCG2ABCB1ABCC1KDM4ECYP3A4 | |
| SCHEMBL29864461 | 0.88 | ADORA3 (1.00) | ABCG2ABCB1ABCC1KDM4ECYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115248-A1 | METHOD FOR PRODUCING BLACK GINGER EXTRACT AND METHOD FOR PRODUCING COMPOSITION | MARUZEN PHARM CO LTD (JP) | 2026-04-30 | — | — | US | claimed |
| US-12514278-B2 | Tobacco-derived composition | R.J. REYNOLDS TOBACCO COMPANY (US) | 2026-01-06 | — | — | US | claimed |
| CN-114867486-B | Composition containing black ginger extract and composition for oral administration | 丸善制药株式会社 | 2023-05-30 | — | — | CN | claimed |
| US-20230021051-A1 | Composition Containing Black Ginger Extract and Composition for Oral Administration | MARUZEN PHARMACEUTICALS CO., LTD. (JP) | 2023-01-19 | — | — | US | claimed |
| WO-2023276167-A1 | SIRTUIN ACTIVATOR | 株式会社常磐植物化学研究所 | 2023-01-05 | — | — | WO | claimed |
| CN-115475157-A | Intestinal barrier improving agent | 株式会社资生堂 | 2022-12-16 | — | — | CN | claimed |
| US-20220346435-A1 | TOBACCO-DERIVED COMPOSITION | REYNOLDS TOBACCO CO R (US) | 2022-11-03 | — | — | US | claimed |
| US-11452756-B2 | Composition and method for improving quantity of tear fluid, composition, treating constipation and improving skin quality | TOKIWA PHYTOCHEMICAL CO., LTD. (JP) | 2022-09-27 | — | — | US | claimed |
| CN-110432537-B | Tobacco-derived O-methylated flavonoid compositions | R.J.雷诺兹烟草公司 | 2022-08-19 | — | — | CN | claimed |
| US-11412775-B2 | Tobacco-derived composition | R.J. REYNOLDS TOBACCO COMPANY (US) | 2022-08-16 | — | — | US | claimed |
| WO-2006132879-A2 | SOFT GEL CAPSULES CONTAINING POLYMETHOXYLATED FLAVONES AND PALM OIL TOCOTRIENOLS | SOFT GEL TECHNOLOGIES, INC. (US) | 2006-12-14 | — | — | WO | claimed |
| US-6987125-B1 | Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2006-01-17 | — | — | US | claimed |
| US-20060003947-A1 | Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols | THE CIT GROUP/CREDIT FINANCE, INC. | 2006-01-05 | — | — | US | claimed |
| US-20050249803-A1 | Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols | SOFT GEL TECHNOLOGIES, INC. | 2005-11-10 | — | — | US | claimed |
| US-6872771-B1 | Tire with rubber containing flavone | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2005-03-29 | — | — | US | claimed |
| JP-2003504327-A | — | — | 2003-02-04 | — | — | JP | claimed |
| EP-1278417-A1 | COMPOSITIONS AND METHODS OF TREATING, REDUCING, AND PREVENTING CARDIOVASCULAR DISEASES AND DISORDERS WITH POLYMETHOXYFLAVONES | KGK Synergie (CA) | 2003-01-29 | — | — | EP | claimed |
| EP-1223928-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | Prendergast, Patrick Thomas (IE) | 2002-07-24 | — | — | EP | claimed |
| WO-2001070029-A1 | COMPOSITIONS AND METHODS OF TREATING, REDUCING, AND PREVENTING CARDIOVASCULAR DISEASES AND DISORDERS WITH POLYMETHOXYFLAVONES | KGK SYNERGIE (CA) | 2001-09-27 | — | — | WO | claimed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050249803-A1 | Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols | TTPA, CCNE2, PTGES | ABCG2 217/4885ABCB1 353/4885ABCC1 1043/4885 |
| US-20260115248-A1 | METHOD FOR PRODUCING BLACK GINGER EXTRACT AND METHOD FOR PRODUCING COMPOSITION | CYP4F8, CYP4F2, CYP4F11 | ABCG2 75/4885ABCB1 159/4885ABCC1 2372/4885 |
| US-20230021051-A1 | Composition Containing Black Ginger Extract and Composition for Oral Administration | CYP4F8, CYP4F2, CYP4F11 | ABCG2 125/4885ABCB1 98/4885ABCC1 921/4885 |
| US-20060003947-A1 | Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols | TTPA, PLA2G10, GSTO1 | ABCG2 143/4885ABCB1 819/4885ABCC1 1668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.